Hypera S.A. – OTC:HYPMY

Hypera S.A. stock price today

$4.17
+1.29
+44.8%
Financial Health
0
1
2
3
4
5
6
7
8
9

Hypera S.A. stock price monthly change

-47.06%
month

Hypera S.A. stock price quarterly change

-47.06%
quarter

Hypera S.A. stock price yearly change

-61.85%
year

Hypera S.A. key metrics

Market Cap
 5.57B
Enterprise value
 18.81B
P/E
 7.22
EV/Sales
 2.41
EV/EBITDA
 7.21
Price/Sales
 1.45
Price/Book
 0.92
PEG ratio
 -0.53
EPS
 2.7
Revenue
 8.04B
EBITDA
 2.88B
Income
 1.70B
Revenue Q/Q
 7.56%
Revenue Y/Y
 3.76%
Profit margin
 20.16%
Oper. margin
 22.83%
Gross margin
 59.9%
EBIT margin
 22.83%
EBITDA margin
 35.82%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Hypera S.A. stock price history

Hypera S.A. stock forecast

Hypera S.A. financial statements

Profit Margin

Hypera S.A. (OTC:HYPMY): Profit margin
Jun 2023 2.23B 503.03M 22.55%
Sep 2023 2.13B 499.42M 23.35%
Dec 2023 1.84B 307.05M 16.63%
Mar 2024 1.82B 392.24M 21.47%
HYPMY income statement history
0.61%
Yield TTM
Hypera S.A. (OTC:HYPMY): Payout ratio
Payout ratio 8.42%
Hypera S.A. (OTC:HYPMY): Dividend Yield
2019 2.73%
2020 3.18%
2021 4.24%
2022 2.87%
2023 3.43%
HYPMY dividends history

Debt to Assets

Hypera S.A. (OTC:HYPMY): Debt to assets
Jun 2023 23810022000 12.75B 53.55%
Sep 2023 24270087000 12.87B 53.03%
Dec 2023 27326002000 15.80B 57.85%
Mar 2024 28152525000 16.42B 58.36%
HYPMY balance sheet history

Cash Flow

Hypera S.A. (OTC:HYPMY): Cash Flow
Jun 2023 578.08M -203.32M 677.34M
Sep 2023 724.37M -237.54M -407.91M
Dec 2023 416.63M -183.17M 129.03M
Mar 2024 232.46M -105.50M 466.59M
HYPMY cash flow history

Hypera S.A. alternative data

Hypera S.A.
Employees

Hypera S.A. (OTC:HYPMY): Employee count
Aug 2023 9,000
Sep 2023 9,000
Oct 2023 9,000
Nov 2023 9,000
Dec 2023 9,000
Jan 2024 9,000
Feb 2024 9,000
Mar 2024 10,301
Apr 2024 10,301
May 2024 10,301
Jun 2024 10,301
Jul 2024 10,301

Hypera S.A. other data

Frequently Asked Questions (FAQ)

  • What's the price of Hypera S.A. stock today?

    One share of Hypera S.A. stock can currently be purchased for approximately $4.17.

  • When is Hypera S.A.'s next earnings date?

    Unfortunately, Hypera S.A.'s (HYPMY) next earnings date is currently unknown.

  • Does Hypera S.A. pay dividends?

    Yes, Hypera S.A. pays dividends and its trailing 12-month yield is 0.61% with 8% payout ratio. The last Hypera S.A. stock dividend of undefined was paid on 6 Sep 2025.

  • How much money does Hypera S.A. make?

    Hypera S.A. has a market capitalization of 5.57B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.88% to 7.91B US dollars.

  • What is Hypera S.A.'s stock symbol?

    Hypera S.A. is traded on the OTC under the ticker symbol "HYPMY".

  • What is Hypera S.A.'s primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Hypera S.A.?

    Shares of Hypera S.A. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Hypera S.A. have?

    As Jul 2024, Hypera S.A. employs 10,301 workers.

  • When Hypera S.A. went public?

    Hypera S.A. is publicly traded company for more then 15 years since IPO on 26 May 2010.

  • What is Hypera S.A.'s official website?

    The official website for Hypera S.A. is hyperapharma.com.br.

  • Where are Hypera S.A.'s headquarters?

    Hypera S.A. is headquartered at Av. MagalhAes de Castro, 4800, São Paulo, SP.

  • How can i contact Hypera S.A.?

    Hypera S.A.'s mailing address is Av. MagalhAes de Castro, 4800, São Paulo, SP and company can be reached via phone at +55 11 3627 4206.

Hypera S.A. company profile:

Exchange:

OTC

Full time employees:

9,000

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

+55 11 3627 4206
Av. MagalhAes de Castro, 4800
São Paulo, SP 05676-120

CIK: 0001486749
ISIN: US44914U1060
: